A nurse is reporting a client's laboratory tests to the provider to obtain a prescription for the client's daily warfarin. Which of the following laboratory tests should the nurse plan to report to obtain the prescription for the warfarin?

A. Platelet count: While a platelet count is important for assessing the risk of bleeding, it is not the primary laboratory test used to monitor the effectiveness of warfarin therapy. B. Fibrinogen level: This test is more relevant in assessing clotting factors and conditions related to bleeding or clotting disorders, but it is not specific for monitoring warfarin. C. aPTT: Activated partial thromboplastin time (aPTT) is primarily used to monitor unfractionated heparin therapy, not warfarin. D. INR: The International Normalized Ratio (INR) is the key laboratory test used to monitor warfarin therapy. It indicates the blood's clotting tendency, and the provider will use this value to determine the appropriate dosage of warfarin. Therefore, it is crucial to report the INR to obtain the prescription for warfarin.